Jialiang Wang Email

SVP, Translational Medicine . Cullgen

Current Roles

Employees:
35
Revenue:
$2.7M
About
Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Our technology, which we call uSMITE™ (ubiquitin-mediated, small molecule-induced target elimination) has the potential to address a broad range of intracellular disease targets, including those representing the up to 80% of proteins that cannot be addressed by existing small molecule therapies, commonly referred to as undruggable targets. In addition to using our uSMITE™ platform to build our own pipeline of protein degradation product candidates, we are also developing a portfolio of novel E3 ligands. You can learn more information about Cullgen on our website: www.Cullgen.com
Cullgen Address
12730 High Bluff Drive
San Diego, CA
Cullgen Email

Past Companies

Cullgen Inc.Senior Vice President, Translational Medicine
Cullgen Inc.VP of Translational Medicine
Cullgen Inc.Executive Director of Discovery Medicine

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.